Cargando…

Patient Preferences for Multi-Cancer Early Detection (MCED) Screening Tests

BACKGROUND: Emerging blood-based multi-cancer early detection (MCED) tests can detect a variety of cancer types across stages with a range of sensitivity, specificity, and ability to predict the origin of the cancer signal. However, little is known about the general US population’s preferences for M...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gelhorn, Heather, Ross, Melissa M., Kansal, Anuraag R., Fung, Eric T., Seiden, Michael V., Krucien, Nicolas, Chung, Karen C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2022
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9813037/ https://www.ncbi.nlm.nih.gov/pubmed/35844011 http://dx.doi.org/10.1007/s40271-022-00589-5

Ejemplares similares

Willingness to Wait for a Vaccine Against COVID-19: Results of a Preference Survey
por: Tervonen, Tommi, et al.
Publicado: (2020)

Estimating the population health impact of a multi-cancer early detection genomic blood test to complement existing screening in the US and UK
por: Hackshaw, Allan, et al.
Publicado: (2021)

Patients' preferences for once‐daily oral versus once‐weekly injectable diabetes medications: The REVISE study
por: Boye, Kristina, et al.
Publicado: (2020)

Otological Features of Patients with Musculocontractural Ehlers–Danlos Syndrome Caused by Pathogenic Variants in CHST14 (mcEDS-CHST14)
por: Kawakita, Masayuki, et al.
Publicado: (2023)

The Potential Value-Based Price of a Multi-Cancer Early Detection Genomic Blood Test to Complement Current Single Cancer Screening in the USA
por: Tafazzoli, Ali, et al.
Publicado: (2022)

Clinical and molecular features of 66 patients with musculocontractural Ehlers−Danlos syndrome caused by pathogenic variants in CHST14 (mcEDS-CHST14)
por: Minatogawa, Mari, et al.
Publicado: (2022)

Patient and physician preferences for attributes of biologic medications for severe asthma
por: Gelhorn, Heather L, et al.
Publicado: (2019)

The Impact of Substantial Improvements in HbA1c and Weight Loss on the Medication Preferences of People with Type 2 Diabetes
por: Gelhorn, Heather L, et al.
Publicado: (2023)

Clinicians' preferences for managing aneurysmal subarachnoid hemorrhage using endothelin receptor antagonists
por: Heidenreich, Sebastian, et al.
Publicado: (2023)

Patients’ with obstructive sleep apnoea syndrome (OSAS) preferences and demand for treatment: a discrete choice experiment
por: Krucien, Nicolas, et al.
Publicado: (2013)

Detailed Courses and Pathological Findings of Colonic Perforation without Diverticula in Sisters with Musculocontractural Ehlers–Danlos Syndrome Caused by Pathogenic Variant in CHST14 (mcEDS-CHST14)
por: Kobayashi, Tomoko, et al.
Publicado: (2023)

Patient and Public Preferences for Coordinated Care in Switzerland: Development of a Discrete Choice Experiment
por: Nicolet, Anna, et al.
Publicado: (2022)

Patient Preferences for Treatment of Bacillus Calmette-Guérin–unresponsive Non–muscle-invasive Bladder Cancer: A Cross-country Choice Experiment
por: Collacott, Hannah, et al.
Publicado: (2023)

P936: EXPLORING HETEROGENEITY IN TREATMENT PREFERENCES OF PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA IN THE UNITED STATES, UNITED KINGDOM, FRANCE, SPAIN, ITALY AND GERMANY
por: Popat, Rakesh, et al.
Publicado: (2023)

Patient preferences for atopic dermatitis medications in the UK, France and Spain: a discrete choice experiment
por: Thomas, Caitlin, et al.
Publicado: (2022)

Preferences for Anaemia Treatment Attributes among Patients with Non-Dialysis-Dependent Chronic Kidney Disease
por: Alexandre, Ana Filipa, et al.
Publicado: (2022)

Preference for pharmaceutical formulation and treatment process attributes
por: Stewart, Katie D, et al.
Publicado: (2016)

Patients with Inflammatory Bowel Disease Have Heterogeneous Treatment Preferences That Are Largely Determined by the Avoidance of Abdominal Pain and Side Effects [P-POWER IBD Study]
por: Louis, Edouard, et al.
Publicado: (2022)

The Benefits of Safely Achieving Near Normoglycemia from the Perspective of People with Type 2 Diabetes: A Quantitative Survey Study
por: Gelhorn, Heather L, et al.
Publicado: (2022)

Evaluating preferences for profiles of GLP-1 receptor agonists among injection-naïve type 2 diabetes patients in the UK
por: Gelhorn, Heather L, et al.
Publicado: (2015)

Patient Preferences of Low-Dose Aspirin for Cardiovascular Disease and Colorectal Cancer Prevention in Italy: A Latent Class Analysis
por: Tervonen, Tommi, et al.
Publicado: (2021)

Evaluating preferences for profiles of glucagon-like peptide-1 receptor agonists among injection-naive type 2 diabetes patients in Japan
por: Gelhorn, Heather L, et al.
Publicado: (2016)

U.K. Intensivists’ Preferences for Patient Admission to ICU: Evidence From a Choice Experiment
por: Bassford, Christopher R., et al.
Publicado: (2019)

Patient and Physician Preferences for Regimen Attributes for the Treatment of HIV in the United States and Canada
por: Gelhorn, Heather, et al.
Publicado: (2022)

The PATHFINDER Study: Assessment of the Implementation of an Investigational Multi-Cancer Early Detection Test into Clinical Practice
por: Nadauld, Lincoln D., et al.
Publicado: (2021)

Health state utility values by cancer stage: a systematic literature review
por: Pourrahmat, Mir-Masoud, et al.
Publicado: (2021)

2499. Perceptions of and Preferences for Oral or Long-Acting Injectable Antiretroviral Treatment Regimens in the United States and Canada
por: Garris, Cindy, et al.
Publicado: (2019)

A Behavioral Test of Accepting Benefits that Cost Others: Associations with Conduct Problems and Callous-Unemotionality
por: Sakai, Joseph T., et al.
Publicado: (2012)

Older adults’ preferences for colorectal cancer-screening test attributes and test choice
por: Kistler, Christine E, et al.
Publicado: (2015)

The Burden and Impacts of Mealtime Insulin from the Perspective of People with Diabetes
por: Paczkowski, R., et al.
Publicado: (2023)

The Promise of Multicancer Early Detection. Comment on Pons-Belda et al. Can Circulating Tumor DNA Support a Successful Screening Test for Early Cancer Detection? The Grail Paradigm. Diagnostics 2021, 11, 2171
por: Klein, Eric A., et al.
Publicado: (2022)

Alzheimer's disease Archimedes condition-event simulator: Development and validation
por: Kansal, Anuraag R., et al.
Publicado: (2018)

The Economic Impact of New Therapeutic Interventions on Neuropsychiatric Inventory (NPI) Symptom Scores in Patients with Alzheimer Disease
por: Tafazzoli, Ali, et al.
Publicado: (2018)

Multi-cancer early detection test sensitivity for cancers with and without current population-level screening options
por: Shao, Spencer H., et al.
Publicado: (2022)

Adaptation and validation of the patient assessment of chronic illness care in the French context
por: Krucien, Nicolas, et al.
Publicado: (2014)

How do study design features and participant characteristics influence willingness to participate in clinical trials? Results from a choice experiment
por: Thomas, Caitlin, et al.
Publicado: (2022)

O052 Patient Preference and Acceptability of Sleep Diagnostic Tests during early Pregnancy
por: Clements, F, et al.
Publicado: (2023)

Assessment of Medical and Public Assistance Expenditures and Employment Among US Adults With Cancer Diagnoses
por: Grabowski, David C., et al.
Publicado: (2023)

Cost‐effectiveness analysis of empagliflozin versus sitagliptin as second‐line therapy for treatment in patients with type 2 diabetes in the United States
por: Reifsnider, Odette, et al.
Publicado: (2020)

Male and Female Veterans’ Preferences for Eating Disorders Screening
por: Hardin, Sabrina, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_b33qerjmcdsslprdg4p7obmbb4